Complete Genomics, Inc.
BioNanomatrix and Complete Genomics, Inc. (CGI) have formed a joint venture that has received an $8.8 million grant award from the U.S. National Institute of Standards and Technology Advanced Technology Program (NIST-ATP) to develop a system capable of sequencing the entire human genome in eight hours at a cost of less than $100. CGI is a high-performance DNA sequencing company whose mission is to dramatically reduce the cost of DNA sequencing for research, drug development, and diagnostic applications.
National Institute of Standards and Technology
BioNanomatrix, in a joint venture with Complete Genomics, Inc., has received an $8.8 million grant award from the U.S. National Institute of Standards and Technology Advanced Technology Program (NIST-ATP) to develop a system capable of sequencing the entire human genome in eight hours at a cost of less than $100. A federal agency within the U.S. Department of Commerce, NIST’s mission is to promote U.S. innovation and industrial competitiveness in ways that enhance economic security and improve our quality of life.
National Human Genome Research Institute
BioNanomatrix has received two grants from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health, including a two-year grant to develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format. The NHGRI supports the development of resources and technology that will accelerate genome research and its application to human health.
National Cancer Institute
BioNanomatrix has formed a number of partnerships with the National Cancer Institute (NCI). These include a project to develop integrated systems that can separate out and sort whole chromosomes from a single cell or multiple cells, a key early step in the analytic process in cancer diagnostics and research and a project to develop methods to detect, identify and quantify DNA damage caused by ionizing radiation. The NCI is a component of the National Institutes of Health (NIH) and is the Federal Government's principal agency for cancer research and training.
Princeton Institute for the Science and Technology of Materials
BioNanomatrix’s technology is licensed exclusively from Princeton University. BioNanomatrix and Princeton are collaborating under an NCI grant to develop integrated systems that can separate out and sort whole chromosomes from a single cell or multiple cells for cancer diagnostics and research. The company is working with the Princeton Institute for the Science and Technology of Materials (PRISM), a multidisciplinary research center in the general field of materials science through photonics with a special emphasis on the hard material–soft material interface.